← TENET HEALTHCARE CORP THC
Market Price
$267.25
Market Cap
$23.01B
P/E Ratio
17.25
Revenue (FY 2025)
↑3.1% YoY
$21.31B
3-Yr CAGR: 3.2%
Net Income
↓-56.0% YoY
$1.41B
Net Margin: 6.6%
Free Cash Flow
↑126.7% YoY
$2.53B
FCF Yield: 10.99%
EPS (Diluted)
↓-52.6% YoY
$15.49
Basic: $15.61
Return on Equity
Efficiency
33.3%
ROA: 4.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (THC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $19,621.0M | — | $7,141.0M | $-192.0M | — | $-1.93 | — | $558.0M | $-317.0M | — |
| FY 2017 | $19,179.0M | -2.3% | $6,820.0M | $-704.0M | -266.7% | $-7.00 | -262.7% | $1,200.0M | $493.0M | +255.5% |
| FY 2018 | $18,313.0M | -4.5% | $6,675.0M | $111.0M | +115.8% | $1.07 | +115.3% | $1,049.0M | $432.0M | -12.4% |
| FY 2019 | $18,479.0M | +0.9% | $6,718.0M | $-232.0M | -309.0% | $-2.24 | -309.3% | $1,233.0M | $563.0M | +30.3% |
| FY 2020 | $18,522.0M | +0.2% | $7,122.0M | $399.0M | +272.0% | $3.75 | +267.4% | $3,407.0M | $2,867.0M | +409.2% |
| FY 2021 | $19,676.0M | +6.2% | $7,470.0M | $914.0M | +129.1% | $8.42 | +124.5% | $1,568.0M | $910.0M | -68.3% |
| FY 2022 | $19,368.0M | -1.6% | $7,251.0M | $411.0M | -55.0% | $3.79 | -55.0% | $1,083.0M | $321.0M | -64.7% |
| FY 2023 | $20,548.0M | +6.1% | $7,812.0M | $611.0M | +48.7% | $5.71 | +50.7% | $2,374.0M | $1,623.0M | +405.6% |
| FY 2024 | $20,665.0M | +0.6% | $8,217.0M | $3,200.0M | +423.7% | $32.70 | +472.7% | $2,047.0M | $1,116.0M | -31.2% |
| FY 2025 | $21,310.0M | +3.1% | $8,825.0M | $1,407.0M | -56.0% | $15.49 | -52.6% | $3,540.0M | $2,530.0M | +126.7% |
Valuation
Market Price
$267.25
Market Cap
$23.01B
Enterprise Value
$33.22B
P/E Ratio
17.25
P/B Ratio
5.46
FCF Yield
10.99%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
41.41%
Operating Margin
16.46%
Net Margin
6.60%
Return on Equity (ROE)
33.34%
Return on Assets (ROA)
4.74%
Asset Turnover
0.72x
Revenue 3-Yr CAGR
3.24%
Financial Health & Liquidity
Current Ratio
1.76
Cash Ratio
0.65
Debt / Equity
3.102
Debt / Assets
0.441
Cash & Equivalents
$2.88B
Total Debt
$13.09B
Book Value / Share
$48.99
Cash Flow Efficiency
Operating Cash Flow
$3.54B
Capital Expenditures (CapEx)
$1.01B
Free Cash Flow
$2.53B
OCF / Revenue
16.61%
FCF / Revenue
11.87%
FCF 3-Yr CAGR
99.01%
Per Share Metrics
EPS (Diluted)
$15.49
EPS (Basic)
$15.61
Dividends / Share
N/A
Book Value / Share
$48.99
EPS YoY Growth
-52.63%
Balance Sheet (FY 2025)
Total Assets
$29.68B
Total Liabilities
$20.70B
Stockholders' Equity
$4.22B
Current Assets
$7.85B
Current Liabilities
$4.46B